Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 7 November 2019

Final settlement with US Department of Justice

Following the press release of 26 June 2019 regarding the settlement in principle, Fagron today announces that it has reached a final settlement with the US Department of Justice regarding the previously announced civil investigation in the context of the sector-wide investigation into the pricing of pharmaceutical products. As previously communicated, and already provided for in the results of the first half of 2019, the final settlement entails a payment by Fagron of US$ 22.3 million.

The settlement agreement with the US Department of Justice does not contain an admission of wrongdoing, fault or liability of any kind by Fagron. With this settlement, all ongoing investigations by the US Department of Justice against Fagron and its subsidiaries will be terminated and there will be no further exposure and associated costs for Fagron.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information
Constantijn van Rietschoten
Chief Communications Officer
Tel. +31 6 53 69 15 85

Please open the link below for the press release:
Final settlement with US Department of Justice